| Convatec Group PLC (CTEC) 6 June 2023 Convatec Group Plc Director/ PDMR Shareholding The Company has been notified of the following transaction in relation to a Person Discharging Managerial Responsibility (“PDMR”) in respect of ordinary shares of 10 pence each in the Company (“Shares”). On 5 June 2023 an award was granted to Karim Bitar, the Company’s Chief Executive Officer under the Company’s Long-Term Incentive Plan (“LTIP”) in the form of Performance Share Units (“PSUs”). This award is due to vest on the third anniversary of grant, conditional upon the following performance measures: organic revenue growth, adjusted profit before tax growth and total shareholder return. A two-year post vesting holding period will apply to this award. The award is subject and conditional upon the Company’s shareholders approving an increase in the Company’s LTIP grant limits at the Company’s 2024 Annual General Meeting. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Enquiries
Louise Bryson, Assistant Company Secretary +44(0)7423 694919
Cosec@convatec.com
Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92
About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com. Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ISIN: | GB00BD3VFW73 |
| Category Code: | DSH |
| TIDM: | CTEC |
| LEI Code: | 213800LS272L4FIDOH92 |
| Sequence No.: | 249002 |
| EQS News ID: | 1650853 |
| End of Announcement | EQS News Service |
| |
